CD274 and neoplasm: Sequential tumor biopsies were taken from metastatic lesions before start of treatment (baseline), after two cycles of low-dose carboplatin as induction treatment (post-induction), and after two cycles of atezolizumab/anti-PD-L1 and continued carboplatin (on-atezolizumab) in patients with metastatic ILC (mILC).